BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11115781)

  • 21. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
    Holland WL; Summers SA
    Endocr Rev; 2008 Jun; 29(4):381-402. PubMed ID: 18451260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis.
    Small GR; Hadoke PW; Sharif I; Dover AR; Armour D; Kenyon CJ; Gray GA; Walker BR
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12165-70. PubMed ID: 16093320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased uncoupling protein-2 mRNA abundance and glucocorticoid action in adipose tissue in the sheep fetus during late gestation is dependent on plasma cortisol and triiodothyronine.
    Gnanalingham MG; Mostyn A; Forhead AJ; Fowden AL; Symonds ME; Stephenson T
    J Physiol; 2005 Aug; 567(Pt 1):283-92. PubMed ID: 15961419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity.
    Kershaw EE; Morton NM; Dhillon H; Ramage L; Seckl JR; Flier JS
    Diabetes; 2005 Apr; 54(4):1023-31. PubMed ID: 15793240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.
    Wang M
    Nutr Metab (Lond); 2005 Feb; 2(1):3. PubMed ID: 15689240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.
    Paterson JM; Morton NM; Fievet C; Kenyon CJ; Holmes MC; Staels B; Seckl JR; Mullins JJ
    Proc Natl Acad Sci U S A; 2004 May; 101(18):7088-93. PubMed ID: 15118095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.
    Masuzaki H; Yamamoto H; Kenyon CJ; Elmquist JK; Morton NM; Paterson JM; Shinyama H; Sharp MG; Fleming S; Mullins JJ; Seckl JR; Flier JS
    J Clin Invest; 2003 Jul; 112(1):83-90. PubMed ID: 12840062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
    Seckl JR; Morton NM; Chapman KE; Walker BR
    Recent Prog Horm Res; 2004; 59():359-93. PubMed ID: 14749510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different responsiveness in body weight and hepatic 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 1 mrna to 11beta-HSD inhibition by glycyrrhetinic acid treatment in obese and lean zucker rats.
    Li RS; Nakagawa Y; Nakanishi T; Fujisawa Y; Ohzeki T
    Metabolism; 2004 May; 53(5):600-6. PubMed ID: 15131764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood?
    Cleasby ME; Livingstone DE; Nyirenda MJ; Seckl JR; Walker BR
    Eur J Endocrinol; 2003 Jan; 148(1):129-38. PubMed ID: 12534366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats.
    Barat P; Livingstone DE; Elferink CM; McDonnell CR; Walker BR; Andrew R
    Endocrinology; 2007 Oct; 148(10):4836-43. PubMed ID: 17628001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.
    Livingstone DE; Jones GC; Smith K; Jamieson PM; Andrew R; Kenyon CJ; Walker BR
    Endocrinology; 2000 Feb; 141(2):560-3. PubMed ID: 10650936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats.
    Livingstone DE; Kenyon CJ; Walker BR
    J Endocrinol; 2000 Dec; 167(3):533-9. PubMed ID: 11115781
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.